Blueprint Medicines Corporation

This study is testing whether the drug avapritinib can better control symptoms in adults with indolent systemic mastocytosis whose symptoms are not well-managed by current standard treatments. It's a Phase 2 trial where some participants receive the drug and others receive a plac…